{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:59:17Z","timestamp":1784638757923,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017051","name":"College of Medicine, Seoul National University","doi-asserted-by":"publisher","award":["0420193020"],"award-info":[{"award-number":["0420193020"]}],"id":[{"id":"10.13039\/100017051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Wilson disease (WD) is a rare genetic disease affecting copper metabolism and the biliary tract\u2019s copper excretion. Lifelong medication is necessary to prevent liver failure, neurological complications, and death. Although D-penicillamine (DPA), trientine, and zinc are used to treat WD, there is limited research on the long-term outcomes of these drugs, especially in children. This study aimed to evaluate the efficacy and safety of DPA, trientine, and zinc in patients diagnosed with WD during childhood.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ninety out of 92 patients were included in the analysis, excluding two patients who underwent liver transplantation without drug treatment due to an acute liver failure diagnosis. Treatment outcomes and reasons for discontinuation of therapy in 148 treatment blocks (37 DPA, 50 trientine, and 61 zinc) were analyzed using Kaplan\u2013Meier analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age at diagnosis was 8.3\u00a0years. There was a statistically significant difference in drug changes due to treatment ineffectiveness among the three drugs: trientine (22\/50, 44%), zinc (15\/61, 25%), and DPA (2\/37, 5%) (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Regarding drug changes due to adverse effects, the rate was the highest for DPA, followed by zinc and trientine. There were significant differences between DPA and zinc, zinc and trientine (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), but no significant difference was observed between DPA and zinc (<jats:italic>p<\/jats:italic>\u2009=\u20090.22).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In pediatric WD, DPA, zinc, and trientine have therapeutic effects in that order. However, DPA and zinc are associated with more adverse effects compared to trientine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-024-03271-1","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:19:59Z","timestamp":1720538399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and safety of D-penicillamine, trientine, and zinc in pediatric Wilson disease patients"],"prefix":"10.1186","volume":"19","author":[{"given":"Eun Joo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hyung","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Soo","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-2974","authenticated-orcid":false,"given":"Jae Sung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"issue":"9559","key":"3271_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","volume":"369","author":"A Ala","year":"2007","unstructured":"Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson\u2019s disease. Lancet. 2007;369(9559):397\u2013408.","journal-title":"Lancet"},{"key":"3271_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-2431-11-56","volume":"11","author":"TY Abdel Ghaffar","year":"2011","unstructured":"Abdel Ghaffar TY, Elsayed SM, Elnaghy S, Shadeed A, Elsobky ES, Schmidt H. Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients. BMC Pediatr. 2011;11:56.","journal-title":"BMC Pediatr"},{"issue":"3","key":"3271_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0006-3223(90)90581-L","volume":"28","author":"TR Dening","year":"1990","unstructured":"Dening TR, Berrios GE. Wilson\u2019s disease: a longitudinal study of psychiatric symptoms. Biol Psychiatry. 1990;28(3):255\u201365.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"3271_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/lt.20352","volume":"11","author":"A Dhawan","year":"2005","unstructured":"Dhawan A, Taylor RM, Cheeseman P, De Silva P, Katsiyiannakis L, Mieli-Vergani G. Wilson\u2019s disease in children: 37-year experience and revised King\u2019s score for liver transplantation. Liver Transpl. 2005;11(4):441\u20138.","journal-title":"Liver Transpl"},{"issue":"4","key":"3271_CR5","first-page":"331","volume":"39","author":"R Iorio","year":"2004","unstructured":"Iorio R, D\u2019Ambrosi M, Marcellini M, Barbera C, Maggiore G, Zancan L, et al. Serum transaminases in children with Wilson\u2019s disease. J Pediatr Gastroenterol Nutr. 2004;39(4):331\u20136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"3271_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5223\/pghn.2015.18.2.121","volume":"18","author":"M Rukunuzzaman","year":"2015","unstructured":"Rukunuzzaman M. Wilson\u2019s Disease in Bangladeshi Children: Analysis of 100 Cases. Pediatr Gastroenterol Hepatol Nutr. 2015;18(2):121\u20137.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"3271_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12423","volume":"1315","author":"SH Hahn","year":"2014","unstructured":"Hahn SH. Population screening for Wilson\u2019s disease. Ann N Y Acad Sci. 2014;1315:64\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"3271_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/B978-0-12-410502-7.00014-4","volume":"110","author":"A Aggarwal","year":"2013","unstructured":"Aggarwal A, Bhatt M. Update on Wilson disease. Int Rev Neurobiol. 2013;110:313\u201348.","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"3271_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"European Association for Study of L","year":"2012","unstructured":"European Association for Study of L. EASL Clinical Practice Guidelines: Wilson\u2019s disease. J Hepatol. 2012;56(3):671\u201385.","journal-title":"J Hepatol"},{"issue":"4","key":"3271_CR10","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2010.12.034","volume":"140","author":"KH Weiss","year":"2011","unstructured":"Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011;140(4):1189-98 e1.","journal-title":"Gastroenterology."},{"issue":"3","key":"3271_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"P Ferenci","year":"2003","unstructured":"Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23(3):139\u201342.","journal-title":"Liver Int"},{"issue":"4","key":"3271_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1440-1746.1990.tb01427.x","volume":"5","author":"M Frydman","year":"1990","unstructured":"Frydman M. Genetic aspects of Wilson\u2019s disease. J Gastroenterol Hepatol. 1990;5(4):483\u201390.","journal-title":"J Gastroenterol Hepatol"},{"issue":"43","key":"3271_CR13","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.3748\/wjg.v23.i43.7716","volume":"23","author":"KS Cheung","year":"2017","unstructured":"Cheung KS, Seto WK, Fung J, Mak LY, Lai CL, Yuen MF. Epidemiology and natural history of Wilson\u2019s disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016. World J Gastroenterol. 2017;23(43):7716\u201326.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3271_CR14","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1468-1331.2009.02946.x","volume":"17","author":"CH Lai","year":"2010","unstructured":"Lai CH, Tseng HF. Population-based epidemiologic study of Wilson\u2019s disease in Taiwan. Eur J Neurol. 2010;17(6):830\u20133.","journal-title":"Eur J Neurol"},{"issue":"1","key":"3271_CR15","doi-asserted-by":"publisher","first-page":"14041","DOI":"10.1038\/s41598-020-70976-1","volume":"10","author":"EJ Choe","year":"2020","unstructured":"Choe EJ, Choi JW, Kang M, Lee YK, Jeon HH, Park BK, et al. A population-based epidemiology of Wilson\u2019s disease in South Korea between 2010 and 2016. Sci Rep. 2020;10(1):14041.","journal-title":"Sci Rep"},{"issue":"6","key":"3271_CR16","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts EA, Schilsky ML, American Association for Study of Liver D. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089\u2013111.","journal-title":"Hepatology"},{"issue":"9","key":"3271_CR17","doi-asserted-by":"publisher","first-page":"720","DOI":"10.7326\/0003-4819-115-9-720","volume":"115","author":"W Stremmel","year":"1991","unstructured":"Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115(9):720\u20136.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3271_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jceh.2018.08.009","volume":"9","author":"A Nagral","year":"2019","unstructured":"Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, et al. Wilson\u2019s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol. 2019;9(1):74\u201398.","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"3271_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MPG.0000000000001787","volume":"66","author":"P Socha","year":"2018","unstructured":"Socha P, Janczyk W, Dhawan A, Baumann U, D\u2019Antiga L, Tanner S, et al. Wilson\u2019s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(2):334\u201344.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"3271_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/hep.32805","volume":"77","author":"ML Schilsky","year":"2023","unstructured":"Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2023;77(4):1428\u201355.","journal-title":"Hepatology"},{"issue":"1","key":"3271_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.dld.2020.11.002","volume":"53","author":"F Di Dato","year":"2021","unstructured":"Di Dato F, Iorio R. Wilson disease: Many guidelines but still many unsolved doubts. Dig Liver Dis. 2021;53(1):139\u201340.","journal-title":"Dig Liver Dis"},{"issue":"6906","key":"3271_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(56)91859-1","volume":"270","author":"JM Walshe","year":"1956","unstructured":"Walshe JM. Wilson\u2019s disease; new oral therapy. Lancet. 1956;270(6906):25\u20136.","journal-title":"Lancet"},{"issue":"263","key":"3271_CR23","first-page":"253","volume":"70","author":"JM Walshe","year":"1989","unstructured":"Walshe JM. Wilson\u2019s disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. Q J Med. 1989;70(263):253\u201363.","journal-title":"Q J Med"},{"issue":"10","key":"3271_CR24","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/01.mcg.0000225670.91722.59","volume":"40","author":"V Medici","year":"2006","unstructured":"Medici V, Trevisan CP, D\u2019Inca R, Barollo M, Zancan L, Fagiuoli S, et al. Diagnosis and management of Wilson\u2019s disease: results of a single center experience. J Clin Gastroenterol. 2006;40(10):936\u201341.","journal-title":"J Clin Gastroenterol"},{"issue":"8","key":"3271_CR25","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cgh.2013.03.012","volume":"11","author":"KH Weiss","year":"2013","unstructured":"Weiss KH, Thurik F, Gotthardt DN, Schafer M, Teufel U, Wiegand F, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11(8):1028-35 e1-2.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1\u20132","key":"3271_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jns.2015.06.010","volume":"355","author":"T Litwin","year":"2015","unstructured":"Litwin T, Dziezyc K, Karlinski M, Chabik G, Czepiel W, Czlonkowska A. Early neurological worsening in patients with Wilson\u2019s disease. J Neurol Sci. 2015;355(1\u20132):162\u20137.","journal-title":"J Neurol Sci"},{"issue":"5","key":"3271_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","volume":"44","author":"GJ Brewer","year":"1987","unstructured":"Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson\u2019s disease with initial penicillamine therapy. Arch Neurol. 1987;44(5):490\u20133.","journal-title":"Arch Neurol"},{"issue":"3\u20134","key":"3271_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000355276","volume":"71","author":"J Kalita","year":"2014","unstructured":"Kalita J, Kumar V, Chandra S, Kumar B, Misra UK. Worsening of Wilson disease following penicillamine therapy. Eur Neurol. 2014;71(3\u20134):126\u201331.","journal-title":"Eur Neurol"},{"issue":"9","key":"3271_CR29","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archneur.1997.00550210092019","volume":"54","author":"S Porzio","year":"1997","unstructured":"Porzio S, Iorio R, Vajro P, Pensati P, Vegnente A. Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation. Arch Neurol. 1997;54(9):1166\u20138.","journal-title":"Arch Neurol"},{"issue":"24","key":"3271_CR30","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.3346\/jkms.2019.34.e173","volume":"34","author":"S Kang","year":"2019","unstructured":"Kang S, Cho MH, Hyun H, Kim JH, Ko JS, Kang HG, et al. A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome. J Korean Med Sci. 2019;34(24):e173.","journal-title":"J Korean Med Sci"},{"key":"3271_CR31","doi-asserted-by":"publisher","first-page":"847436","DOI":"10.3389\/fphar.2022.847436","volume":"13","author":"S Tang","year":"2022","unstructured":"Tang S, Bai L, Hou W, Hu Z, Chen X, Zhao J, et al. Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022;13:847436.","journal-title":"Front Pharmacol"},{"issue":"167","key":"3271_CR32","first-page":"441","volume":"42","author":"JM Walshe","year":"1973","unstructured":"Walshe JM. Copper chelation in patients with Wilson\u2019s disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med. 1973;42(167):441\u201352.","journal-title":"Q J Med"},{"issue":"7755","key":"3271_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0140-6736(72)90845-8","volume":"1","author":"HB Dixon","year":"1972","unstructured":"Dixon HB, Gibbs K, Walshe JM. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson\u2019s disease. Lancet. 1972;1(7755):853.","journal-title":"Lancet"},{"issue":"27","key":"3271_CR34","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.3748\/wjg.v19.i27.4356","volume":"19","author":"A Wiernicka","year":"2013","unstructured":"Wiernicka A, Janczyk W, Dadalski M, Avsar Y, Schmidt H, Socha P. Gastrointestinal side effects in children with Wilson\u2019s disease treated with zinc sulphate. World J Gastroenterol. 2013;19(27):4356\u201362.","journal-title":"World J Gastroenterol"},{"issue":"1\u20132","key":"3271_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0048-9697(85)90005-1","volume":"42","author":"TU Hoogenraad","year":"1985","unstructured":"Hoogenraad TU, Dekker AW, van den Hamer CJ. Copper responsive anemia, induced by oral zinc therapy in a patient with acrodermatitis enteropathica. Sci Total Environ. 1985;42(1\u20132):37\u201343.","journal-title":"Sci Total Environ"},{"issue":"2","key":"3271_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/mus.21425","volume":"40","author":"A Foubert-Samier","year":"2009","unstructured":"Foubert-Samier A, Kazadi A, Rouanet M, Vital A, Lagueny A, Tison F, et al. Axonal sensory motor neuropathy in copper-deficient Wilson\u2019s disease. Muscle Nerve. 2009;40(2):294\u20136.","journal-title":"Muscle Nerve"},{"issue":"3","key":"3271_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.pjnns.2014.05.002","volume":"48","author":"K Dziezyc","year":"2014","unstructured":"Dziezyc K, Litwin T, Sobanska A, Czlonkowska A. Symptomatic copper deficiency in three Wilson\u2019s disease patients treated with zinc sulphate. Neurol Neurochir Pol. 2014;48(3):214\u20138.","journal-title":"Neurol Neurochir Pol"},{"issue":"3","key":"3271_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.lab.2005.01.007","volume":"145","author":"M Marcellini","year":"2005","unstructured":"Marcellini M, Di Ciommo V, Callea F, Devito R, Comparcola D, Sartorelli MR, et al. Treatment of Wilson\u2019s disease with zinc from the time of diagnosis in pediatric patients: a single-hospital, 10-year follow-up study. J Lab Clin Med. 2005;145(3):139\u201343.","journal-title":"J Lab Clin Med"},{"issue":"1","key":"3271_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jgh.13812","volume":"33","author":"K Eda","year":"2018","unstructured":"Eda K, Mizuochi T, Iwama I, Inui A, Etani Y, Araki M, et al. Zinc monotherapy for young children with presymptomatic Wilson disease: A multicenter study in Japan. J Gastroenterol Hepatol. 2018;33(1):264\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"3271_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1172-9-41","volume":"9","author":"G Ranucci","year":"2014","unstructured":"Ranucci G, Di Dato F, Spagnuolo MI, Vajro P, Iorio R. Zinc monotherapy is effective in Wilson\u2019s disease patients with mild liver disease diagnosed in childhood: a retrospective study. Orphanet J Rare Dis. 2014;9:41.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"3271_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/MPG.0b013e31821d5abe","volume":"53","author":"T Mizuochi","year":"2011","unstructured":"Mizuochi T, Kimura A, Shimizu N, Nishiura H, Matsushita M, Yoshino M. Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease. J Pediatr Gastroenterol Nutr. 2011;53(4):365\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"3271_CR42","doi-asserted-by":"publisher","first-page":"e86168","DOI":"10.1371\/journal.pone.0086168","volume":"9","author":"K Abuduxikuer","year":"2014","unstructured":"Abuduxikuer K, Wang JS. Zinc mono-therapy in pre-symptomatic Chinese children with Wilson disease: a single center, retrospective study. PLoS ONE. 2014;9(1):e86168.","journal-title":"PLoS ONE"},{"issue":"1","key":"3271_CR43","first-page":"68","volume":"11","author":"V Delle Cave","year":"2024","unstructured":"Delle Cave V, Di Dato F, Iorio R. Wilson\u2019s Disease with Acute Hepatic Onset: How to Diagnose and Treat It. Children (Basel). 2024;11(1):68.","journal-title":"Children (Basel)."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03271-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03271-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03271-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T17:04:05Z","timestamp":1720544645000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03271-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,9]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3271"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03271-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,9]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Seoul National University Children\u2019s Hospital (IRB No. 1909\u2013111-1066), Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}